Azora Therapeutics, Inc. - 8-K Filing
Azora Therapeutics appoints three new directors and completes conversion of Series A Preferred Stock into 9.92 million common shares. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $ADIL